Virginia Lallana-Meca
Madrid, MD 28006, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
XVIII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2025 ECTRIMS Congress (Part II)
Journal: Revista de neurologia
Published: March 10, 2026
XVIII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2025 ECTRIMS Congress (Part I)
Journal: Revista de neurologia
Published: March 10, 2026
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.
Journal: Therapeutic advances in neurological disorders
Published: January 14, 2026
How do neurologists perceive the organization and functioning of multiple sclerosis care units?
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: October 02, 2025
XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (II)
Journal: Revista de neurologia
Published: March 24, 2025
XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (I)
XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (I)
Journal: Revista de neurologia
Published: March 24, 2025
Neurologists' Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants.
Journal: Neuropsychiatric disease and treatment
Published: February 23, 2025
Attitudes of Neurologists Toward Serum Neurofilament Light-Chain Testing in the Management of Relapsing-Remitting Multiple Sclerosis with Cognitive Impairment.
Journal: Journal of personalized medicine
Published: December 25, 2024
Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.
Journal: Frontiers in immunology
Published: November 26, 2024
Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study.
Journal: Clinical drug investigation
Published: September 17, 2024
Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.
Journal: Frontiers in immunology
Published: August 14, 2024
Observational study of gadolinium-enhancing lesions in MRI in patients with multiple sclerosis from the Spanish Mediterranean coast: Seasonal variability and relationship with climatic factors.
Journal: Multiple sclerosis and related disorders
Published: July 25, 2024
Last Updated: 09/26/2026